EnteraStim is an early stage medical device company that is developing innovative and proprietary approaches to treating intestinal motility disorders such as ileus, which affects millions of patients in the US annually. The EnteraStim System is based on technology already tested in both animal and human trials. We have strong IP. The market is estimated at $1B with limited therapeutic options.